Several down, a few to go: histamine H3receptor ligands making the final push towards the market?-Reference-Cited by-同舟云学术

Several down, a few to go: histamine H3receptor ligands making the final push towards the market?

Published:2011-10-13 Issue:12 Volume:20 Page:1629-1648
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Kuhne Sebastiaan¹,Wijtmans Maikel²,Lim Herman D³,Leurs Rob¹³,de Esch Iwan JP¹³

Affiliation:

1. VU University Amsterdam, Leiden/Amsterdam Center for Drug Research (LACDR), Division of Medicinal Chemistry, Department of Pharmacochemistry, Faculty of Exact Sciences, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands

2. VU University Amsterdam, Leiden/Amsterdam Center for Drug Research (LACDR), Division of Medicinal Chemistry, Department of Pharmacochemistry, Faculty of Exact Sciences, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands ; ;

3. Griffin Discoveries BV, Department of Medicinal Chemistry, Room P-246, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2011.625010

Reference76 articles.

1. The role of histamine and the tuberomamillary nucleus in the nervous system

2. Molecular and biochemical pharmacology of the histamine H4 receptor

3. Keynote review: Histamine H3 receptor antagonists reach out for the clinic

4. The histamine H3 receptor: from gene cloning to H3 receptor drugs

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Administration of oxathridine, a first‐in‐class histamine‐3 receptor partial agonist in healthy male volunteers: Central nervous system depression and pseudo‐hallucinations;British Journal of Clinical Pharmacology;2023-10-11

2. SAR exploration of the non‐imidazole histamine H ₃ receptor ligand ZEL‐H16 reveals potent inverse agonism;Archiv der Pharmazie;2022-10-30

3. Histamine H3 receptor antagonists – Roles in neurological and endocrine diseases and diabetes mellitus;Biomedicine & Pharmacotherapy;2022-06

4. 1‐[2‐(1‐Cyclobutylpiperidin‐4‐yloxy)‐6,7‐dihydro‐4 H ‐thiazolo[5,4‐ c ]pyridin‐5‐yl]propan‐1‐one: a Histamine H 3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition;ChemMedChem;2021-11-18

5. Biogenic amines in the colon;Postępy Higieny i Medycyny Doświadczalnej;2021-03-11